Cover Image

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline

Eric Leibert, Mauricio Danckers, William N Rom Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, NY, USA Abstract: Mycobacterium tuberculosis develops spontaneous resistance mutants to virtually every drug in u...

Full description

Saved in:

Bibliographic Details
Main Authors:	Leibert E (Author), Danckers M (Author), Rom WN (Author)
Format:	Book
Published:	Dove Medical Press, 2014-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of bedaquiline containing all oral longer regimens in treating multidrug/rifampicin resistant tuberculosis in Pakistan
by: Asad Khan, et al.
Published: (2024)

Identification of urine biomarkers predictive of prolonged QTc interval in multidrug-resistant tuberculosis patients treated with bedaquiline
by: Jiajia Yu, et al.
Published: (2024)

Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety
by: Jing-Tao Gao, et al.
Published: (2021)

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients
by: Ge Shao, et al.
Published: (2023)

Extensively drug-resistant tuberculosis treated with bedaquiline: A case report in the particularly vulnerable tribal group of Madhya Pradesh, India
by: Prashant Mishra, et al.
Published: (2021)

Efficacy of Tuberculosis Treatment in Patients with Drug-Resistant Tuberculosis with the Use of Bedaquiline: The Experience of the Russian Federation
by: Anna Starshinova, et al.
Published: (2022)

Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data
by: I Gusti Agung Ayu Putu Sri Darmayani, et al.
Published: (2022)

The efficacy of bedaquiline versus kanamycin in multi-drug resistant tuberculosis: A systematic scoping review
by: Lisa Singh, et al.
Published: (2021)

Clinical course of pregnancy and postpartum in a multidrug-resistant tuberculosis/HIV co-infected patient receiving bedaquiline-containing regimen as antimycobacterial therapy
by: О.М. Raznatovska, et al.
Published: (2019)

Investigation of bedaquiline resistance and genetic mutations in multi-drug resistant Mycobacterium tuberculosis clinical isolates in Chongqing, China
by: Yan Hu, et al.
Published: (2023)

Evaluation of the effectiveness of bedaquiline and delamanid treatment among children and adolescents with multi-drug-resistant pulmonary tuberculosis
by: M.I. Sakhelashvili, et al.
Published: (2023)

The need to accelerate access to new drugs for multidrug-resistant tuberculosis
by: Helen S Cox, et al.
Published: (2015)

Exposure-safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug‐resistant tuberculosis
by: Lénaïg Tanneau, et al.
Published: (2021)

Development of Bedaquiline-Loaded SNEDDS Using Quality by Design (QbD) Approach to Improve Biopharmaceutical Attributes for the Management of Multidrug-Resistant Tuberculosis (MDR-TB)
by: Rao Nargis Jahan, et al.
Published: (2023)

The importance of heteroresistance and efflux pumps in bedaquiline-resistant Mycobacterium tuberculosis isolates from Iran
by: Nahid Madadi-Goli, et al.
Published: (2024)

TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION
by: A.E. ERGESHOV, et al.
Published: (2018)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017)

Prevalence of drug-resistant recurrent tuberculosis and new multidrug-resistant tuberculosis mutations detection in Can Tho, Vietnam
by: Loan Thi Duong, et al.
Published: (2022)

The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data
by: Shanshan Li, et al.
Published: (2024)

ANTITUBERCULOSIS DRUG ALLERGY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: B.B. MAYKANAEV, et al.
Published: (2021)

Whole Genome Sequencing for the Analysis of Drug Resistant Strains of <i>Mycobacterium tuberculosis</i>: A Systematic Review for Bedaquiline and Delamanid
by: Luisa Maria Nieto Ramirez, et al.
Published: (2020)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021)

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis
by: Louvina E. van der Laan, et al.
Published: (2021)

Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline
by: Yangming Ding, et al.
Published: (2023)

Multidrug-resistant tuberculosis today
by: A Matteelli, et al.

Multidrug-resistant tuberculosis today
by: A Matteelli, et al.
Published: (2012)

Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid.
by: Juliano Timm, et al.
Published: (2023)

Drug resistance in pulmonary tuberculosis in new and previously treated cases: Experience from Turkey
by: Berna Komurcuoglu, et al.
Published: (2013)

Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration
by: Sara E. Maloney, et al.
Published: (2023)

Individualised treatment for multidrug‐resistant tuberculosis in New South Wales, Australia
by: Vicky Chang, et al.
Published: (2021)

Nomogram to predict multidrug-resistant tuberculosis
by: Saibin Wang, et al.
Published: (2020)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018)

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
by: Hoa Binh Nguyen, et al.
Published: (2016)

Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework
by: Pablos-Méndez Ariel, et al.
Published: (2002)

Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility
by: Kaspars Lunte, et al.

Drug resistance detection and mutation patterns of multidrug resistant tuberculosis strains from children in Delhi
by: Jyoti Arora, et al.
Published: (2019)

Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization
by: Basanth Babu Eedara, et al.
Published: (2023)

Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis
by: Kai Blöndal

Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia
by: Fanta Desissa, et al.
Published: (2018)

Representations on adherence to the treatment of Multidrug-Resistant Tuberculosis
by: Kuitéria Ribeiro Ferreira, et al.
Published: (2018)